Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells

Wen Sen Lee, Chao Wei Liu, Shu Hui Juan, Yu Chih Liang, Pei Yin Ho, Yi-Hsuan Lee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Previously we demonstrated that progesterone at physiologic levels dose dependently inhibited cell proliferation in cultured rat aortic smooth muscle cells (RASMCs). However, the molecular mechanism underlying of progesterone-induced antiproliferation was not clear. Here we demonstrated that progesterone induced a reduction of the [3H]thymidine incorporation into RASMCs during the S-phase of the cell cycle. Western blotting analysis revealed that the protein levels of cyclin A, cyclin E, and cyclin-dependent-kinase (CDK) 2 but not cyclin D1 and CDK4 decreased after progesterone treatment, but those of CDK-inhibitory proteins, p21 and p27, increased. Immunoprecipitation showed that the formations of the CDK2-p21 and CDK2-p27 complex were increased and the assayable CDK2 kinase activity was decreased in the progesterone-treated RASMCs. In contrast, the formations of the CDK4-p21 and CDK4-p27 complex and the assayable CDK4 kinase activity were not changed significantly by progesterone treatment. Pretreatment of RASMCs with a p21 or p27 antisense oligonucleotide reduced the progesterone-induced inhibition of [3H]thymidine incorporation into RASMCs. In conclusion, these data suggest that progesterone inhibits RASMCs proliferation by increasing the levels of p21 and p27 protein, which in turn inhibit CDK2 kinase activity, and finally interrupt the cell cycle.

Original languageEnglish
Pages (from-to)2785-2790
Number of pages6
JournalEndocrinology
Volume144
Issue number7
DOIs
Publication statusPublished - Jul 1 2003

Fingerprint

Smooth Muscle Myocytes
Progesterone
Phosphotransferases
Thymidine
Cell Cycle
Cell Proliferation
Cyclin-Dependent Kinase 2
Cyclin A
Cyclin E
Cyclin-Dependent Kinases
Antisense Oligonucleotides
Cyclin D1
S Phase
Immunoprecipitation
Proteins
Western Blotting

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells. / Lee, Wen Sen; Liu, Chao Wei; Juan, Shu Hui; Liang, Yu Chih; Ho, Pei Yin; Lee, Yi-Hsuan.

In: Endocrinology, Vol. 144, No. 7, 01.07.2003, p. 2785-2790.

Research output: Contribution to journalArticle

@article{a36f6e93bec84b3b8c08240c4bc3d26c,
title = "Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells",
abstract = "Previously we demonstrated that progesterone at physiologic levels dose dependently inhibited cell proliferation in cultured rat aortic smooth muscle cells (RASMCs). However, the molecular mechanism underlying of progesterone-induced antiproliferation was not clear. Here we demonstrated that progesterone induced a reduction of the [3H]thymidine incorporation into RASMCs during the S-phase of the cell cycle. Western blotting analysis revealed that the protein levels of cyclin A, cyclin E, and cyclin-dependent-kinase (CDK) 2 but not cyclin D1 and CDK4 decreased after progesterone treatment, but those of CDK-inhibitory proteins, p21 and p27, increased. Immunoprecipitation showed that the formations of the CDK2-p21 and CDK2-p27 complex were increased and the assayable CDK2 kinase activity was decreased in the progesterone-treated RASMCs. In contrast, the formations of the CDK4-p21 and CDK4-p27 complex and the assayable CDK4 kinase activity were not changed significantly by progesterone treatment. Pretreatment of RASMCs with a p21 or p27 antisense oligonucleotide reduced the progesterone-induced inhibition of [3H]thymidine incorporation into RASMCs. In conclusion, these data suggest that progesterone inhibits RASMCs proliferation by increasing the levels of p21 and p27 protein, which in turn inhibit CDK2 kinase activity, and finally interrupt the cell cycle.",
author = "Lee, {Wen Sen} and Liu, {Chao Wei} and Juan, {Shu Hui} and Liang, {Yu Chih} and Ho, {Pei Yin} and Yi-Hsuan Lee",
year = "2003",
month = "7",
day = "1",
doi = "10.1210/en.2003-0045",
language = "English",
volume = "144",
pages = "2785--2790",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells

AU - Lee, Wen Sen

AU - Liu, Chao Wei

AU - Juan, Shu Hui

AU - Liang, Yu Chih

AU - Ho, Pei Yin

AU - Lee, Yi-Hsuan

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Previously we demonstrated that progesterone at physiologic levels dose dependently inhibited cell proliferation in cultured rat aortic smooth muscle cells (RASMCs). However, the molecular mechanism underlying of progesterone-induced antiproliferation was not clear. Here we demonstrated that progesterone induced a reduction of the [3H]thymidine incorporation into RASMCs during the S-phase of the cell cycle. Western blotting analysis revealed that the protein levels of cyclin A, cyclin E, and cyclin-dependent-kinase (CDK) 2 but not cyclin D1 and CDK4 decreased after progesterone treatment, but those of CDK-inhibitory proteins, p21 and p27, increased. Immunoprecipitation showed that the formations of the CDK2-p21 and CDK2-p27 complex were increased and the assayable CDK2 kinase activity was decreased in the progesterone-treated RASMCs. In contrast, the formations of the CDK4-p21 and CDK4-p27 complex and the assayable CDK4 kinase activity were not changed significantly by progesterone treatment. Pretreatment of RASMCs with a p21 or p27 antisense oligonucleotide reduced the progesterone-induced inhibition of [3H]thymidine incorporation into RASMCs. In conclusion, these data suggest that progesterone inhibits RASMCs proliferation by increasing the levels of p21 and p27 protein, which in turn inhibit CDK2 kinase activity, and finally interrupt the cell cycle.

AB - Previously we demonstrated that progesterone at physiologic levels dose dependently inhibited cell proliferation in cultured rat aortic smooth muscle cells (RASMCs). However, the molecular mechanism underlying of progesterone-induced antiproliferation was not clear. Here we demonstrated that progesterone induced a reduction of the [3H]thymidine incorporation into RASMCs during the S-phase of the cell cycle. Western blotting analysis revealed that the protein levels of cyclin A, cyclin E, and cyclin-dependent-kinase (CDK) 2 but not cyclin D1 and CDK4 decreased after progesterone treatment, but those of CDK-inhibitory proteins, p21 and p27, increased. Immunoprecipitation showed that the formations of the CDK2-p21 and CDK2-p27 complex were increased and the assayable CDK2 kinase activity was decreased in the progesterone-treated RASMCs. In contrast, the formations of the CDK4-p21 and CDK4-p27 complex and the assayable CDK4 kinase activity were not changed significantly by progesterone treatment. Pretreatment of RASMCs with a p21 or p27 antisense oligonucleotide reduced the progesterone-induced inhibition of [3H]thymidine incorporation into RASMCs. In conclusion, these data suggest that progesterone inhibits RASMCs proliferation by increasing the levels of p21 and p27 protein, which in turn inhibit CDK2 kinase activity, and finally interrupt the cell cycle.

UR - http://www.scopus.com/inward/record.url?scp=0038336905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038336905&partnerID=8YFLogxK

U2 - 10.1210/en.2003-0045

DO - 10.1210/en.2003-0045

M3 - Article

C2 - 12810531

AN - SCOPUS:0038336905

VL - 144

SP - 2785

EP - 2790

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 7

ER -